What is the greatest regulatory challenge in the translation of biomaterials to the clinic?

Glenn D. Prestwich, Sangeeta N Bhatia, Christopher K. Breuer, Shannon L M Dahl, Chris W Mason, Richard McFarland, David J. McQuillan, Jonathan Sackner-Bernstein, Jefrey Schox, William E. Tente, Alan Trounson

Research output: Contribution to journalComment / DebateOtherpeer-review

51 Citations (Scopus)

Abstract

Leaders in the f eld comment on what they perceive to be the greatest barriers to biomaterial translation.

Original languageEnglish
Article number160cm14
JournalScience Translational Medicine
Volume4
Issue number160
DOIs
Publication statusPublished - 14 Nov 2012
Externally publishedYes

Cite this